The Seattle based medical device startup creates products for both human and animal health. Recently, the company received funding and a federal grant for their DripAssist device that can improve the treatment of Ebola.
The device is a low-cost, battery-powered infusion monitor that measures IV drips to eliminate the risk of fluid overload. DripAssist improves the accuracy of hydration, reduces the workload for healthcare providers, speeds up treatment, and reduces costs.
The product hasn’t been approved by the FDA yet and is not available for sale in the U.S., at this time, for use in human patients. However, the DripAssist is available for use in animals...
View Article Here